Krsnaa Diagnostics · NSE: KRSNAA · BSE: 543328

Q4 FY23 results · Jan–Mar 2023

Krsnaa Diagnostics reported revenue from operations of ₹133.23 crore (up 23.1% from Q4 FY22) and net profit of ₹18.92 crore (up 5.5% from Q4 FY22) for Q4 FY23 (Jan–Mar 2023), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY23Q4 FY22YoYQ3 FY23QoQ
Revenue from operations133.23108.25+23.1%118.10+12.8%
Other income5.934.10+44.4%4.54+30.4%
Total income139.15112.35+23.9%122.64+13.5%
Profit before tax23.5819.89+18.6%17.78+32.6%
Net profit for the period18.9217.94+5.5%13.64+38.7%
EPS, basic (₹)6.035.40+11.7%4.35+38.6%
Net margin (%)14.216.611.6
Standalone · ₹ crore
ItemQ4 FY23Q4 FY22YoYQ3 FY23QoQ
Revenue from operations115.86107.84+7.4%115.74+0.1%
Other income5.944.12+44.1%4.55+30.5%
Total income121.80111.97+8.8%120.29+1.3%
Profit before tax14.2022.06−35.6%22.17−35.9%
Net profit for the period11.8119.33−38.9%16.86−30.0%
EPS, basic (₹)3.765.85−35.7%5.37−30.0%
Net margin (%)10.217.914.6
Consolidated
Filed with BSE
27 May 2023, 22:50 IST
Board meeting
27 May 2023
Period
01 Jan 2023 to 31 Mar 2023
Review status
Audited
Source
XBRL filing on BSE
Standalone
Filed with BSE
27 May 2023, 22:50 IST
Board meeting
27 May 2023
Period
01 Jan 2023 to 31 Mar 2023
Review status
Audited
Source
XBRL filing on BSE